tetano
Editor, Senior Moderator
Am J Transplant. 2020 May 5. doi: 10.1111/ajt.15970. [Epub ahead of print]
Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients.
Montagud-Marrahi E[SUP]1[/SUP], Cofan F[SUP]1[/SUP], Torregrosa JV[SUP]1[/SUP], Cucchiari D[SUP]1,[/SUP][SUP]2[/SUP], Ventura-Aguiar P[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Revuelta I[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Bodro M[SUP]4,[/SUP][SUP]5[/SUP], Pi?eiro GJ[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Esforzado N[SUP]1[/SUP], Ugalde J[SUP]1,[/SUP][SUP]2[/SUP], Guill?n E[SUP]1[/SUP], Rodr?guez-Espinosa D[SUP]1[/SUP], Campistol JM[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Oppenheimer F[SUP]1,[/SUP][SUP]2[/SUP], Moreno A[SUP]4,[/SUP][SUP]5[/SUP], Diekmann F[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Since the first cases of Coronavirus Disease 2019(COVID-19) were identified on December 12[SUP]th[/SUP] , 2019, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has dramatically spread worldwide becoming a pandemic with devastating consequences[SUP]1[/SUP] . This exponential increase in COVID-19 cases also includes vulnerable populations such as kidney recipients[SUP]2,3[/SUP] . Although scarce, preliminary information in this population suggests a serious course with a mortality of up to 25%[SUP]4[/SUP] . Herein, we report the outcomes of a cohort of 33 kidney transplant recipients from a single center focusing on hospital and intensive care (ICU) admission and mortality.
This article is protected by copyright. All rights reserved.
PMID:32368838DOI:10.1111/ajt.15970
Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients.
Montagud-Marrahi E[SUP]1[/SUP], Cofan F[SUP]1[/SUP], Torregrosa JV[SUP]1[/SUP], Cucchiari D[SUP]1,[/SUP][SUP]2[/SUP], Ventura-Aguiar P[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Revuelta I[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Bodro M[SUP]4,[/SUP][SUP]5[/SUP], Pi?eiro GJ[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Esforzado N[SUP]1[/SUP], Ugalde J[SUP]1,[/SUP][SUP]2[/SUP], Guill?n E[SUP]1[/SUP], Rodr?guez-Espinosa D[SUP]1[/SUP], Campistol JM[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Oppenheimer F[SUP]1,[/SUP][SUP]2[/SUP], Moreno A[SUP]4,[/SUP][SUP]5[/SUP], Diekmann F[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Since the first cases of Coronavirus Disease 2019(COVID-19) were identified on December 12[SUP]th[/SUP] , 2019, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has dramatically spread worldwide becoming a pandemic with devastating consequences[SUP]1[/SUP] . This exponential increase in COVID-19 cases also includes vulnerable populations such as kidney recipients[SUP]2,3[/SUP] . Although scarce, preliminary information in this population suggests a serious course with a mortality of up to 25%[SUP]4[/SUP] . Herein, we report the outcomes of a cohort of 33 kidney transplant recipients from a single center focusing on hospital and intensive care (ICU) admission and mortality.
This article is protected by copyright. All rights reserved.
PMID:32368838DOI:10.1111/ajt.15970